Nonlethal Inhibition of Gut Microbial Trimethylamine N‐oxide Production Improves Cardiac Function and Remodeling in a Murine Model of Heart Failure

Journal of the American Heart Association - Tập 9 Số 10 - 2020
Chelsea L. Organ1, Zhen Li1, Thomas E. Sharp1, David J. Polhemus1, Nilaksh Gupta2, Traci Goodchild1, W.H. Wilson Tang2,3, Stanley L. Hazen2,3, David J. Lefer1
1Cardiovascular Center of Excellence Louisiana State University Health Sciences Center New Orleans LA
2Center for Microbiome and Human Health Department of Cardiovascular and Metabolic Sciences Lerner Research Institute Cleveland Clinic Cleveland OH
3Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Cleveland, OH

Tóm tắt

Background Patients at increased risk for coronary artery disease and adverse prognosis during heart failure exhibit increased levels of circulating trimethylamine N‐oxide ( TMAO ), a metabolite formed in the metabolism of dietary phosphatidylcholine. We investigated the efficacy of dietary withdrawal of TMAO as well as use of a gut microbe‐targeted inhibitor of TMAO production, on cardiac function and structure during heart failure. Methods and Results Male C57 BLK /6J mice were fed either control diet, a diet containing TMAO (0.12% wt/wt), a diet containing choline (1% wt/wt), or a diet containing choline (1% wt/wt) plus a microbial choline trimethylamine lyase inhibitor, iodomethylcholine (0.06% wt/wt), starting 3 weeks before transverse aortic constriction. At 6 weeks after transverse aortic constriction, a subset of animals in the TMAO group were switched to a control diet for the remainder of the study. Left ventricular structure and function were monitored at 3‐week intervals. Withdrawal of TMAO from the diet attenuated adverse ventricular remodeling and improved cardiac function compared with the TMAO group. Similarly, inhibiting gut microbial conversion of choline to TMAO with a choline trimethylamine lyase inhibitor, iodomethylcholine, improved remodeling and cardiac function compared with the choline‐fed group. Conclusions These experimental findings are clinically relevant, and they demonstrate that TMAO levels are modifiable following long‐term exposure periods with either dietary withdrawal of TMAO or gut microbial blockade of TMAO generation. Furthermore, these therapeutic strategies to reduce circulating TMAO levels mitigate the negative effects of dietary choline and TMAO in heart failure.

Từ khóa


Tài liệu tham khảo

10.1161/CIR.0000000000000757

10.1016/j.cardfail.2019.03.007

10.1371/journal.pbio.1002533

10.1038/nature08821

10.1038/nature11053

10.1146/annurev.mi.31.100177.000543

10.1093/ajcn/25.12.1292

10.1194/jlr.M051680

10.1016/j.celrep.2014.12.036

Sheard NF, Zeisel SH. Choline: an essential dietary nutrient? Nutrition. 1989;5:1–5.

10.1111/j.1753-4887.2009.00246.x

10.1016/S0065-3101(24)00054-9

10.1016/j.jacc.2014.02.617

10.1056/NEJMoa1109400

10.1161/CIRCRESAHA.116.305360

10.1038/nature09922

10.1038/nm.3145

10.1111/j.1365-2796.2010.02270.x

10.1073/pnas.1011383107

10.1074/jbc.M114.618249

10.1161/JAHA.115.002767

10.1016/j.cell.2016.02.011

10.1161/CIRCULATIONAHA.116.025338

10.1016/j.cell.2015.11.055

10.1161/ATVBAHA.119.312592

10.1161/CIRCRESAHA.118.313142

10.1111/jth.14234

10.1136/heartjnl-2015-308826

10.1111/joim.12328

10.1016/j.cardfail.2014.11.006

Zhou X, Jin M, Liu L, Yu Z, Lu X, Zhang H. Trimethylamine N‐oxide and cardiovascular outcomes in patients with chronic heart failure after myocardial infarction. ESC Heart Fail. 2020;7:188–193.

10.1111/jcmm.13307

10.1093/eurheartj/ehx342

10.1161/CIRCHEARTFAILURE.115.002314

10.1016/j.jacbts.2018.08.011

10.1161/circheartfailure.113.000299

10.1152/ajpheart.00515.2017

10.1152/ajpheart.00603.2017

10.1161/circresaha.115.308278

10.1016/j.jacc.2017.08.056

10.1016/j.cmet.2014.10.006

10.1016/j.ab.2014.03.016

10.1093/eurheartj/ehy799

10.1038/s41591-018-0128-1

10.1161/CIR.0000000000000450

10.2174/1389200003339135

10.1016/j.pharmthera.2005.01.001

10.1021/cb500113p

10.3390/molecules23030549

10.1371/journal.pone.0141738

10.1161/CIRCULATIONAHA.112.000855

10.1016/j.cmet.2019.08.021

10.1016/j.str.2009.07.015

10.1093/eurheartj/ehy799

Thông tin
Thông tin xuất bản

Journal of the American Heart Association

Tập 9 Số 10

Thông tin tác giả